Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists - Archive ouverte HAL Access content directly
Conference Papers Journal of Translational Medicine Year : 2012

Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists

(1, 2) , (2, 1) , (2, 1) , (2, 1)
1
2

Domains

Life Sciences [q-bio] Human health and pathology Life Sciences [q-bio] Human health and pathology Urology and Nephrology
Fichier principal
Vignette du fichier
1479-5876-10-S3-O2.pdf (119.96 Ko) Télécharger le fichier
Vignette du fichier
1479-5876-10-S3-O2.xml (4.64 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Ed. BMC  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00758217

Submitted on : Wednesday, November 28, 2012-1:09:41 PM

Last modification on : Wednesday, April 27, 2022-4:21:51 AM

Long-term archiving on: Saturday, December 17, 2016-4:00:12 PM

Download

Dates and versions

inserm-00758217 , version 1 (28-11-2012)

Identifiers

  • HAL Id : inserm-00758217 , version 1

Cite

Nicolas Poirier, Nahzli Dilek, Caroline Mary, Bernard Vanhove. Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists. 7th European Workshop on Immune-Mediated Inflammatory Diseases, Nov 2012, Netherlands. pp.O2. ⟨inserm-00758217⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-NANTES NANTES-UNIVERSITE
50 View
105 Download

Share

Gmail Facebook Twitter LinkedIn More